Xufei Du

484 total citations
9 papers, 248 citations indexed

About

Xufei Du is a scholar working on Immunology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xufei Du has authored 9 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Physiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xufei Du's work include Asthma and respiratory diseases (4 papers), Pediatric health and respiratory diseases (3 papers) and Neonatal Respiratory Health Research (2 papers). Xufei Du is often cited by papers focused on Asthma and respiratory diseases (4 papers), Pediatric health and respiratory diseases (3 papers) and Neonatal Respiratory Health Research (2 papers). Xufei Du collaborates with scholars based in China, Portugal and United States. Xufei Du's co-authors include Zhihua Chen, Fei Li, Huahao Shen, Zhehua Shao, Songmin Ying, Wen Li, Yicheng He, Zhenyu Ju, Songmin Ying and Man Luo and has published in prestigious journals such as Science Advances, Nature Chemical Biology and Cell Research.

In The Last Decade

Xufei Du

9 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xufei Du China 7 92 73 66 59 37 9 248
Sam Jackson United Kingdom 9 95 1.0× 68 0.9× 17 0.3× 83 1.4× 17 0.5× 20 343
Lauren Chad Canada 9 63 0.7× 50 0.7× 24 0.4× 24 0.4× 17 0.5× 28 287
Catarina Mota Portugal 10 80 0.9× 38 0.5× 28 0.4× 16 0.3× 19 0.5× 22 256
Genay Pilarowski United States 11 104 1.1× 180 2.5× 57 0.9× 44 0.7× 19 0.5× 14 468
Meihua Wu United States 9 71 0.8× 60 0.8× 38 0.6× 21 0.4× 22 0.6× 22 354
Yujuan Xiang China 13 38 0.4× 61 0.8× 93 1.4× 11 0.2× 59 1.6× 25 338
Claire Brady Ireland 8 73 0.8× 90 1.2× 68 1.0× 25 0.4× 23 0.6× 24 329
Fabien Rondepierre France 11 64 0.7× 93 1.3× 21 0.3× 10 0.2× 13 0.4× 26 309
Linda Clarke Australia 9 79 0.9× 281 3.8× 12 0.2× 25 0.4× 36 1.0× 9 430
Paula Araya United States 10 136 1.5× 77 1.1× 54 0.8× 15 0.3× 26 0.7× 20 321

Countries citing papers authored by Xufei Du

Since Specialization
Citations

This map shows the geographic impact of Xufei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufei Du more than expected).

Fields of papers citing papers by Xufei Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufei Du. The network helps show where Xufei Du may publish in the future.

Co-authorship network of co-authors of Xufei Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xufei Du. A scholar is included among the top collaborators of Xufei Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufei Du. Xufei Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Li, Fei, Hao‐Yu Tang, Qian Wu, et al.. (2025). Iron Drives Eosinophil Differentiation in Allergic Airway Inflammation Through Mitochondrial Metabolic Adaptation. Advanced Healthcare Materials. 14(7). e2405085–e2405085. 2 indexed citations
2.
Li, Fei, Xufei Du, Fen Lan, et al.. (2021). Eosinophilic inflammation promotes CCL6-dependent metastatic tumor growth. Science Advances. 7(22). 42 indexed citations
3.
Shao, Zhehua, Qingya Shen, Bingpeng Yao, et al.. (2021). Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1. Nature Chemical Biology. 18(3). 264–271. 56 indexed citations
4.
He, Yicheng, Fei Li, Chao Zhang, et al.. (2021). Therapeutic Effects of the Bcl-2 Inhibitor on Bleomycin-induced Pulmonary Fibrosis in Mice. Frontiers in Molecular Biosciences. 8. 645846–645846. 11 indexed citations
5.
Du, Xufei, Fei Li, Chao Zhang, et al.. (2021). Eosinophil-derived chemokine (hCCL15/23, mCCL6) interacts with CCR1 to promote eosinophilic airway inflammation. Signal Transduction and Targeted Therapy. 6(1). 91–91. 43 indexed citations
6.
Wu, Mindan, Chen Min, Jun Wu, et al.. (2020). Prevalence and risk factors of mental distress in China during the outbreak of COVID‐19: A national cross‐sectional survey. Brain and Behavior. 10(11). e01818–e01818. 37 indexed citations
7.
Du, Xufei, Fei Li, Zhehua Shao, et al.. (2019). CCL6 produced by eosinophils drives allergic airway inflammation in mice. PA4363–PA4363. 2 indexed citations
8.
Zhang, Chao, Weiwei Yi, Fei Li, et al.. (2018). Eosinophil-derived CCL-6 impairs hematopoietic stem cell homeostasis. Cell Research. 28(3). 323–335. 30 indexed citations
9.
Lai, Tianwen, Mindan Wu, Chao Zhang, et al.. (2018). HDAC2 attenuates airway inflammation by suppressing IL-17A production in HDM-challenged mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 316(1). L269–L279. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026